Metis Global Partners LLC purchased a new position in Amrize Ltd (NYSE:AMRZ – Free Report) in the second quarter, Holdings Channel.com reports. The institutional investor purchased 12,723 shares of the company’s stock, valued at approximately $635,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC bought a new position in shares of Amrize during the 2nd quarter worth about $62,646,000. Hiddenite Capital Partners LP bought a new position in Amrize in the second quarter worth approximately $12,388,000. TD Asset Management Inc bought a new position in Amrize in the second quarter worth approximately $8,190,000. Allianz Asset Management GmbH acquired a new stake in Amrize in the second quarter valued at approximately $158,530,000. Finally, Bessemer Group Inc. acquired a new stake in Amrize in the second quarter valued at approximately $16,489,000.
Analysts Set New Price Targets
A number of brokerages recently issued reports on AMRZ. Wall Street Zen upgraded Amrize to a “hold” rating in a report on Saturday, October 25th. Oddo Bhf began coverage on shares of Amrize in a research note on Monday, November 3rd. They issued a “neutral” rating on the stock. Morgan Stanley set a $61.00 price objective on shares of Amrize and gave the company an “overweight” rating in a report on Wednesday, October 29th. JPMorgan Chase & Co. upped their target price on shares of Amrize from $52.00 to $60.00 and gave the stock an “overweight” rating in a report on Tuesday, August 26th. Finally, Citigroup lifted their price target on Amrize from $60.00 to $63.00 and gave the company a “buy” rating in a research note on Monday, November 3rd. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $58.71.
Amrize Price Performance
AMRZ opened at $50.03 on Thursday. Amrize Ltd has a fifty-two week low of $44.12 and a fifty-two week high of $56.29. The company has a market capitalization of $27.67 billion and a price-to-earnings ratio of 27.19. The firm’s 50-day moving average price is $50.30. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.38 and a quick ratio of 0.85.
Amrize (NYSE:AMRZ – Get Free Report) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $0.98 EPS for the quarter, missing the consensus estimate of $1.01 by ($0.03). The company’s revenue was up 6.6% compared to the same quarter last year.
Insiders Place Their Bets
In other Amrize news, insider Jaime Hill acquired 4,000 shares of Amrize stock in a transaction on Tuesday, November 4th. The stock was purchased at an average price of $50.69 per share, for a total transaction of $202,760.00. Following the purchase, the insider directly owned 18,101 shares of the company’s stock, valued at $917,539.69. This trade represents a 28.37% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Stephen S. Clark bought 5,000 shares of the firm’s stock in a transaction dated Friday, August 15th. The shares were acquired at an average cost of $51.82 per share, with a total value of $259,100.00. Following the completion of the transaction, the insider owned 5,000 shares in the company, valued at approximately $259,100. The trade was a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last three months, insiders purchased 74,500 shares of company stock valued at $3,900,655.
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Further Reading
- Five stocks we like better than Amrize
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Rare Earth Stocks: The Truce That Isn’t a Truce
- What Are the U.K. Market Holidays? How to Invest and Trade
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- Energy and Oil Stocks Explained
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
